Guanine derivative
US6107302A · kind A · utility
65Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 22, 1997 |
| Grant date | Aug 22, 2000 |
| Priority date | — |
| Expiry date | Sep 22, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to an anhydrous crystalline form of (2-[2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy]ethyl L-valinate hydrochloride (otherwise known as valaciclovir hydrochloride) and a process for preparing it.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.